Daewoong pharmaceutical

069620.KO

118.14 USD

-1.22

-1.02%

Overview

Last close

118.14 usd

Market cap

1.36B usd

52 week high

122.67 usd

52 week low

72.15 usd

Target price

148.53 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.2803

Price/Book Value

2.2977

Enterprise Value

1.77B usd

EV/Revenue

1.6705

EV/EBITDA

19.2792

Key financials

Revenue TTM

1.06B usd

Gross Profit TTM

548.36M usd

EBITDA TTM

149.90M usd

Earnings per Share

N/A usd

Dividend

0.44 usd

Total assets

1.35B usd

Net debt

N/A usd

About

Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.